Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (201-210 of 607) with videos related to

Pageof 61
Sort By:
Clinical and Experimental Rheumatology|October 18, 2016
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisisBernadette M Lynch, Edward P Stern, Voon Ong, et al.
Journal of Autoimmunity|March 5, 2022
Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccinationAlice Cole, Rhys Thomas, Nina Goldman, et al.
Clinical and Experimental Dermatology|November 18, 2003
Etanercept-induced systemic lupus erythematosusV J Swale, C M Perrett, C P Denton, et al.
Arthritis Research & Therapy|October 7, 2005
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosisVineeth S Rajkumar, Kevin Howell, Katalin Csiszar, et al.
Rheumatology (Oxford, England)|December 17, 2009
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblastsXu Shi-wen, Mark Eastwood, Richard J Stratton, et al.
Archives of Dermatological Research|March 13, 2023
Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsiesAmanda M Saracino, Daniel Kelberman, Georg W Otto, et al.
Current Opinion in Rheumatology|September 20, 2022
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culpritVishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Lancet (London, England)|January 24, 2012
Haemopoietic stem-cell transplantation for systemic sclerosisKeith M Sullivan, Frederick M Wigley, Christopher P Denton, et al.
The Journal of Rheumatology|December 4, 2009
Observational study of treatment outcome in early diffuse cutaneous systemic sclerosisAriane L Herrick, Mark Lunt, Nina Whidby, et al.
Annals of the Rheumatic Diseases|June 30, 2016
Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohortYannick Allanore, Christopher P Denton, Thomas Krieg, et al.
Pageof 61

Showing results (201-210 of 607) with videos related to

Sort By:
Pageof 61
Clinical and Experimental Rheumatology|October 18, 2016
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisisBernadette M Lynch, Edward P Stern, Voon Ong, et al.
Journal of Autoimmunity|March 5, 2022
Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccinationAlice Cole, Rhys Thomas, Nina Goldman, et al.
Clinical and Experimental Dermatology|November 18, 2003
Etanercept-induced systemic lupus erythematosusV J Swale, C M Perrett, C P Denton, et al.
Arthritis Research & Therapy|October 7, 2005
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosisVineeth S Rajkumar, Kevin Howell, Katalin Csiszar, et al.
Rheumatology (Oxford, England)|December 17, 2009
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblastsXu Shi-wen, Mark Eastwood, Richard J Stratton, et al.
Archives of Dermatological Research|March 13, 2023
Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsiesAmanda M Saracino, Daniel Kelberman, Georg W Otto, et al.
Current Opinion in Rheumatology|September 20, 2022
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culpritVishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Lancet (London, England)|January 24, 2012
Haemopoietic stem-cell transplantation for systemic sclerosisKeith M Sullivan, Frederick M Wigley, Christopher P Denton, et al.
The Journal of Rheumatology|December 4, 2009
Observational study of treatment outcome in early diffuse cutaneous systemic sclerosisAriane L Herrick, Mark Lunt, Nina Whidby, et al.
Annals of the Rheumatic Diseases|June 30, 2016
Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohortYannick Allanore, Christopher P Denton, Thomas Krieg, et al.
Pageof 61